Lindbrook Capital, LLC Emergent Bio Solutions Inc. Transaction History
Lindbrook Capital, LLC
- $1.09 Billion
- Q4 2024
A detailed history of Lindbrook Capital, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 101 shares of EBS stock, worth $577. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101
Previous 101
-0.0%
Holding current value
$577
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EBS
# of Institutions
174Shares Held
36.8MCall Options Held
336KPut Options Held
203K-
Black Rock Inc. New York, NY3.84MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$18.3 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$12.2 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$11.2 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$8.81 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $285M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...